Showing results (11-20 of 185) with videos related to
Sort By:
Pageof 19
The Canadian Journal of Urology|April 30, 2014
The changing landscape of advanced and castration resistant prostate cancer: latest science and revised definitionsDerya Tilki, Christopher P EvansCurrent Opinion in Urology|August 10, 2004
Old friends, new ways: revisiting extended lymphadenectomy and neoadjuvant chemotherapy to improve outcomesJ Erik Busby, Christopher P EvansThe Canadian Journal of Urology|February 7, 2008
Current management of small renal massesMichelle L Ramírez, Christopher P EvansUrologic Oncology|December 30, 2008
Oncogenic activation of androgen receptorHsing-Jien Kung, Christopher P EvansThe Journal of Urology|July 11, 2003
Long-term safety and efficacy of tamsulosin for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasiaPerinchery Narayan, Christopher P Evans, Timothy MoonUrologic Oncology|September 7, 2010
What is the optimal management of high risk, clinically localized prostate cancer?James A Eastham, Christopher P Evans, Anthony ZietmanWorld Journal of Urology|September 7, 2002
Minimally invasive therapies for benign prostatic hyperplasiaHari Siva Gurunadha Rao Tunuguntla, Christopher P EvansCurrent Opinion in Urology|March 6, 2012
Economic analysis of active surveillance for localized prostate cancerSun Kim, Marc A Dall'Era, Christopher P EvansOncotarget|October 4, 2014
Molecular pathways and targets in prostate cancerEmma Shtivelman, Tomasz M Beer, Christopher P EvansEuropean Urology Focus|July 21, 2017
Understanding Mechanisms of Resistance in Metastatic Castration-resistant Prostate Cancer: The Role of the Androgen ReceptorDerya Tilki, Edward M Schaeffer, Christopher P EvansPageof 19